BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19859052)

  • 1. Metabolic consequences of peritoneal dialysis treatment.
    Gallieni M; Musetti C; Granata A; Olivi L; Bertoli S
    Panminerva Med; 2009 Sep; 51(3):175-85. PubMed ID: 19859052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of malnutrition in peritoneal dialysis patients].
    Lobbedez T; Pujo M; el Haggan W; Hurault de Ligny B; Levaltier B; Ryckelynck JP
    Nephrologie; 2003; 24(7):387-9. PubMed ID: 14650752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
    Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
    Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for dietary protein intake in CAPD patients.
    Piraino B
    Adv Perit Dial; 1996; 12():275-9. PubMed ID: 8865918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure.
    Kalantar-Zadeh K; Mehrotra R; Fouque D; Kopple JD
    Semin Dial; 2004; 17(6):455-65. PubMed ID: 15660576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic tools for dyslipidemia in peritoneal dialysis patients.
    Scarpioni R
    J Nephrol; 2009; 22(1):46-58. PubMed ID: 19229818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Lindholm B; Bergström J
    Clin Nephrol; 1988; 30 Suppl 1():S59-63. PubMed ID: 3141094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional issues in peritoneal dialysis patients: how do they differ from that of patients undergoing hemodialysis?
    Mehrotra R
    J Ren Nutr; 2013 May; 23(3):237-40. PubMed ID: 23611553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis.
    Tjiong HL; van den Berg JW; Wattimena JL; Rietveld T; van Dijk LJ; van der Wiel AM; van Egmond AM; Fieren MW; Swart R
    J Am Soc Nephrol; 2005 May; 16(5):1486-93. PubMed ID: 15800130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for managing diabetic patients on peritoneal dialysis.
    Dasgupta MK
    Adv Perit Dial; 2004; 20():200-2. PubMed ID: 15384826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malnutrition and chronic renal failure].
    Cano N
    Ann Med Interne (Paris); 2000 Nov; 151(7):563-574. PubMed ID: 11139657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible peritoneal dialysis solutions: do we have one?
    Chaudhary K; Khanna R
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition in dialysis patients.
    Sharma RK; Sahu KM
    J Indian Med Assoc; 2001 Apr; 99(4):206-8, 210-1, 213. PubMed ID: 11666026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid solutions for CAPD: rationale and clinical experience.
    Jones MR; Martis L; Algrim CE; Bernard D; Swartz R; Messana J; Bergström J; Lindholm B; Lim V; Serkes KD
    Miner Electrolyte Metab; 1992; 18(2-5):309-15. PubMed ID: 1465081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies.
    Chiu YW; Kopple JD; Mehrotra R
    Semin Nephrol; 2009 Jan; 29(1):67-74. PubMed ID: 19121476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with body-fat changes in prevalent peritoneal dialysis patients.
    Vasselai P; Kamimura MA; Bazanelli AP; Pupim LB; Avesani CM; da Mota Ribeiro FS; Manfredi SR; Draibe SA; Cuppari L
    J Ren Nutr; 2008 Jul; 18(4):363-9. PubMed ID: 18558301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of continuous ambulatory peritoneal dialysis.
    Lindholm B; Alvestrand A; Fürst P; Karlander SG; Norbeck HE; Ahlberg M; Tranaeus A; Bergström J
    Proc Eur Dial Transplant Assoc; 1980; 17():283-90. PubMed ID: 7243780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients.
    Choi HY; Lee JE; Han SH; Yoo TH; Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
    Nephrol Dial Transplant; 2010 Apr; 25(4):1266-71. PubMed ID: 19926717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.